Resources
Considerations for developing and deploying cost and economic impact models in the elimination/control of 5 PCT NTDs
The economic impact model and supporting disease-specific tools estimate the direct and indirect economic impact, efficiencies, and societal benefits of investing in NTD programs and interventions. The workshop will explain how NTD programs can use the supporting tools to develop investment cases to advocate for domestic resources and prioritize NTD investments in a multi-disease environment. It will also describe how, with support from HKI and Deloitte, Sierra Leone’s NTD program will pilot these tools and serve as the advisor on country needs, program and financial data, user testing of the tools, and utilization of the outputs for advocacy. After incorporating the feedback from the pilot in Sierra Leone, the Act | West team will make the tools available to all supported countries to create investment cases that enhance advocacy efforts for domestic resource mobilization for NTD programming.
Improving Mass Drug Administration Tools
The Carter Center's Emily Griswold presents on improving mass drug administration tools on January 16, 2020.
Lymphatic Filariasis Operational Research Updates from NTDSC
Updates on operational research for lymphatic filariasis were shared from the Neglected Tropical Diseases Support Center on January 16, 2020.
High Quality Disease-Specific Assessment Implementation and Electronic Data Collection
RTI's Clara Burgert and Diana Lu talk about how to ensure high-quality standardized surveys on January 16, 2020.
Investigating and Responding to LF Survey Failures
RTI's Clara Burgert leads a panel discussion on how to investigate and respond to LF survey failures on January 15, 2020.
Transmission Assessment Survey Preparation and Supervision
IMA World Health's Abdel Direny, MD, MPH, presented guidance for transmission assessment survey preparation and supervision on January 15, 2020.
USAID NTD Division - Overview of Lymphatic Filariasis
USAID's Emily Toubali provided an overview of the NTD Division's work on lymphatic filariasis on January 14, 2020
Filariasis Test Strip Quality and Reporting
The US Center for Disease Control and Prevention's Caitlin Worrell discussed filariasis test strip quality as a diagnostic tool and reporting issues with the tool on January 14, 2020.
Excerpts from Community-based health care, including outreach and campaigns, in the context of the COVID-19 pandemic
Interim guidance May 2020
Published by the World Health Organization and the United Nations Children’s Fund (UNICEF)
Diagnostic Test Guidance
Tara Brandt of the US Centers for Disease Control and Prevention provided guidance on using diagnostic tests—particularly filariasis test strips—for diagnosing LF on January 14, 2020.